off label glp 1 Specialty Physicians on Using GLP-1 Drugs GlucoVantage and Supresa Key Benefits Revolutionizing Weight Loss: The Power

For chronic weight management, the FDA-approved indications generally include adults with a BMI of 30 or greater, or BMI 27 or greater with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease)

Reagent Sets contain Capture Antibody, Detection Antibody, Recombinant Standard, HRP Conjugate, TMB Substrate and Stop Solution

GLP-1 use has been shown to lead to meaningful weight loss and to greatly reduce the likelihood of conditions and complications associated with obesity, such as cardiovascular disease, and some GLP-1s have also been associated with other desirable health outcomes, such as decreased risk of depression or anxiety

Then your manager is looking at Clover Lange and Rocky

While linear interpolation provides reasonable estimates for visualization purposes, actual weight loss may not follow perfectly linear trajectories between anchor points